Insiders Lotus Pharmaceutical Co., Ltd.

Equities

1795

TW0001795003

End-of-day quote Taiwan S.E. Other stock markets 23:00:00 23/05/2024 BST			5-day change	1st Jan Change
280 ^TWD	-0.36%		-6.98%	+2.94%

05-11	Lotus Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-26	Lotus Pharmaceutical Co., Ltd. Announces Change in Representative of the Company's Institutional Director	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lotus Pharmaceutical Co., Ltd. Announces Change in Representative of the Company's Institutional Director	03-26	CI
Lotus Pharmaceutical Co., Ltd. Announces the Appointment of Valerie Lau as APAC Chief Commercial Officer, Effective February 15, 2024	01-31	CI
Lotus Pharmaceutical Co., Ltd. Announces Director Changes	04/09/23	CI
Lotus Pharmaceutical Co., Ltd. Appoints Susan Liao as Acting Spokesperson	10/07/23	CI
Lotus Pharmaceutical Co., Ltd. Announces Appointment of the Remuneration Committee Members	10/07/23	CI
Lotus Pharmaceutical Co., Ltd. Announces Board Changes	15/06/23	CI
Lotus Pharmaceutical Co., Ltd. Announces Tenure Expiration of the Remuneration Committee Members	15/06/23	CI
Lotus Pharmaceutical Co., Ltd. Announces Change in Audit Committee Members	15/06/23	CI
Lotus Pharmaceutical Co., Ltd. Announces Change of Directors	15/06/23	CI
Lotus Pharmaceutical Co., Ltd. Announces Executive Changes	23/11/22	CI
Lotus Pharmaceutical Co., Ltd. Announces Election of Directors	30/06/22	CI
Lotus Pharmaceutical Co., Ltd. Announces Resignation of Hirofumi Imai as Director, Effective June 30, 2022	12/04/22	CI
Lotus Pharmaceutical Co., Ltd. Announces Change of the Representative of Institutional Director	27/01/22	CI
Lotus Pharmaceutical Co., Ltd. Announces Appointment of Gwen Hsieh as Chief Information Officer, Effective August 2, 2021	29/07/21	CI
Lotus Pharmaceutical Co., Ltd. Announces Change of the Representative of Institutional Director	22/04/21	CI
Lotus Pharmaceutical Co., Ltd. Appoints Hanfei Lin as Remuneration Committee Members	13/08/20	CI
Lotus Pharmaceutical Co., Ltd. Announces Retirement of Eddy Cheung as Member of the Remuneration Committee	15/06/20	CI
Lotus Pharmaceutical Co., Ltd. Announces Executive Changes	08/07/19	CI
Lotus Pharmaceutical Co., Ltd. Announces Election of Hirofumi Imai as Director, Effective from June 26, 2019	24/06/19	CI
Lotus Pharmaceutical Co., Ltd. Announces Board Changes	11/03/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Lotus Pharmaceutical Co., Ltd.

Equities

1795

TW0001795003

Insiders

Filters